BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22069486)

  • 21. CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.
    Juarez JG; Thien M; Dela Pena A; Baraz R; Bradstock KF; Bendall LJ
    Br J Haematol; 2009 May; 145(4):491-9. PubMed ID: 19344405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.
    Melo RCC; Longhini AL; Bigarella CL; Baratti MO; Traina F; Favaro P; de Melo Campos P; Saad ST
    PLoS One; 2014; 9(1):e85926. PubMed ID: 24497931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
    Grymula K; Tarnowski M; Wysoczynski M; Drukala J; Barr FG; Ratajczak J; Kucia M; Ratajczak MZ
    Int J Cancer; 2010 Dec; 127(11):2554-68. PubMed ID: 20162608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.
    Lapidot T
    Ann N Y Acad Sci; 2001 Jun; 938():83-95. PubMed ID: 11458529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
    Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds.
    Shen ZH; Zeng DF; Kong PY; Ma YY; Zhang X
    Blood Cells Mol Dis; 2016 Jul; 59():16-24. PubMed ID: 27282562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
    Alsayed Y; Ngo H; Runnels J; Leleu X; Singha UK; Pitsillides CM; Spencer JA; Kimlinger T; Ghobrial JM; Jia X; Lu G; Timm M; Kumar A; Côté D; Veilleux I; Hedin KE; Roodman GD; Witzig TE; Kung AL; Hideshima T; Anderson KC; Lin CP; Ghobrial IM
    Blood; 2007 Apr; 109(7):2708-17. PubMed ID: 17119115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling.
    Spiegel A; Kollet O; Peled A; Abel L; Nagler A; Bielorai B; Rechavi G; Vormoor J; Lapidot T
    Blood; 2004 Apr; 103(8):2900-7. PubMed ID: 15070661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
    Hirbe AC; Morgan EA; Weilbaecher KN
    Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
    Chen Z; Teo AE; McCarty N
    Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.
    Parameswaran R; Yu M; Lim M; Groffen J; Heisterkamp N
    Leukemia; 2011 Aug; 25(8):1314-23. PubMed ID: 21483439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression and clinical significance of stromal cell-derived factor-1 and CXCR4 in acute leukemia and malignant lymphoma].
    Zeng DF; Kong PY; Chen XH; Wei L; Chang C; Peng XG
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):522-4. PubMed ID: 16080846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells.
    Nakamura T; Shinriki S; Jono H; Guo J; Ueda M; Hayashi M; Yamashita S; Zijlstra A; Nakayama H; Hiraki A; Shinohara M; Ando Y
    Oncotarget; 2015 Jan; 6(2):1008-19. PubMed ID: 25504440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
    Dillenburg-Pilla P; Patel V; Mikelis CM; Zárate-Bladés CR; Doçi CL; Amornphimoltham P; Wang Z; Martin D; Leelahavanichkul K; Dorsam RT; Masedunskas A; Weigert R; Molinolo AA; Gutkind JS
    FASEB J; 2015 Mar; 29(3):1056-68. PubMed ID: 25466898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
    Juarez J; Dela Pena A; Baraz R; Hewson J; Khoo M; Cisterne A; Fricker S; Fujii N; Bradstock KF; Bendall LJ
    Leukemia; 2007 Jun; 21(6):1249-57. PubMed ID: 17410186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.
    Bradstock KF; Makrynikola V; Bianchi A; Shen W; Hewson J; Gottlieb DJ
    Leukemia; 2000 May; 14(5):882-8. PubMed ID: 10803521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.
    Gentilini A; Rombouts K; Galastri S; Caligiuri A; Mingarelli E; Mello T; Marra F; Mantero S; Roncalli M; Invernizzi P; Pinzani M
    J Hepatol; 2012 Oct; 57(4):813-20. PubMed ID: 22727731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
    Juarez J; Bradstock KF; Gottlieb DJ; Bendall LJ
    Leukemia; 2003 Jul; 17(7):1294-300. PubMed ID: 12835717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
    Welschinger R; Liedtke F; Basnett J; Dela Pena A; Juarez JG; Bradstock KF; Bendall LJ
    Exp Hematol; 2013 Mar; 41(3):293-302.e1. PubMed ID: 23178377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of CXCR4 in the progression and therapy of acute leukaemia.
    Su L; Hu Z; Yang YG
    Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.